Delivery Order SPE2DX22D0079-SPE2D825FAFC8
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, valued at $4,863.93 with a firm fixed price contract type. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $109,461.87 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,264.90 to AmerisourceBergen Drug Corp on August 5, 2025, with a completion deadline of August 6, 2025. This firm fixed-price delivery order, classified as a child contract under the company's larger indefinite delivery vehicle with DLA Troop Support Medical, represents a competitively awarded, non-set-aside transaction. The award was made to AmerisourceBergen's Corporate Office division, headquartered...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,138.61 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded under an Indefinite Delivery Contract vehicle. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,672.43 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office division. The contract will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. As a child order under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $49,806.00 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is set to be completed by August 5, 2025. The award carries no set-aside designation and reflects AmerisourceBergen's established role as a critical pharmaceutical...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D825FAFC8Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,893.28 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued as a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle, represents a small pharmaceutical procurement. The award was not set-aside and was competitively awarded, reflecting the vendor's established capability to meet federal medical procurement standards. The contract specifies performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company holds a prime indefinite delivery contract valued at $999,999,999.00 through December 2026, which enables it to supply an expansive portfolio of pharmaceutical products and medical supplies—including specialty medications, vaccines, generic and brand-name drugs, and medical devices—to support global military healthcare programs. This delivery order exemplifies the company's ongoing role in fulfilling routine pharmaceutical supply requirements for the Defense Health Agency and other federal healthcare systems through the DLA's flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/1/25 |